Selected Publications

Academic Article

Year Title Altmetric
2019 Pathologic Predictors of Local Recurrence in Atypical Meningiomas Following Gross Total Resection.International Journal of Radiation Oncology - Biology - Physics.  103:453-459. 2019
2019 Longitudinal assessment of anchored transponder migration following lung stereotactic body radiation therapy.Journal of Applied Clinical Medical Physics.  20:17-22. 2019
2019 Prostate Stereotactic Body Radiation Therapy With a Focal Simultaneous Integrated Boost: Acute Toxicity and Dosimetry Results From a Prospective Trial.Advances in Radiation Oncology.  4:90-95. 2019
2018 How Would MRI-targeted Prostate Biopsy Alter Radiation Therapy Approaches in Treating Prostate Cancer?Urology.  122:139-146. 2018
2018 Case Studies in Clinical Practice Management: Patient Demographics and Referral Patterns for [F-18]Fluciclovine-PET Imaging at a Tertiary Academic Medical Center.Journal of the American College of Radiology2018
2018 Brain dosimetry from locally advanced head and neck cancer radiotherapy: implications for neurocognitive outcomes research.Acta Oncologica.  57:1589-1592. 2018
2018 Sarcopenia & aging in cancer.Journal of Geriatric Oncology2018
2017 Dynamics of the vaginal wall dose in HDR interstitial brachytherapy for gynecological cancer: Systematic analysis of phantom vs patient case.Medical Dosimetry.  43:237-242. 2017
2017 Fractionated stereotactic radiation therapy for intact brain metastases.Advances in Radiation Oncology.  2:564-571. 2017
2017 Gait Speed and Survival in Patients With Brain Metastases.Journal of Pain and Symptom Management.  54:105-109. 2017
2017 CT Measures of Bone Mineral Density and Muscle Mass Can Be Used to Predict Noncancer Death in Men with Prostate Cancer.Radiology.  282:475-483. 2017
2017 Distant brain recurrence in patients with five or more newly diagnosed brain metastases treated with focal stereotactic radiotherapy alone.Journal of Radiosurgery and SBRT.  4:255-263. 2017
2017 Subcutaneous adipose tissue characteristics and the risk of biochemical recurrence in men with high-risk prostate cancer.Urologic Oncology: Seminars and Original Investigations.  35:663.e15-663.e21. 2017
2016 Long-term results of a phase I/II trial of the addition of celecoxib to chemoradiotherapy for locally advanced or recurrent squamous cell carcinoma of the head-and-neckJournal of Radiation Oncology.  5:363-369. 2016
2016 Mesorectal node metastasis from gynecological cancer in the era of 3D conformal pelvic radiation therapy and intensity modulated radiation therapy.Practical Radiation Oncology.  6:402-404. 2016
2016 Impact of adjuvant chemoradiation on survival in patients with resectable cholangiocarcinoma.HPB.  18:843-850. 2016
2016 Evaluating the Role of Urinalysis for Suspected Cystitis in Women Undergoing Pelvic Radiotherapy.International Journal of Gynecological Cancer2016
2016 Factors associated with increased incidence of severe toxicities following yttrium-90 resin microspheres in the treatment of hepatic malignancies.World Journal of Gastroenterology.  22:3006-3014. 2016
2016 Combining Computed Tomography-Based Bone Density Assessment with FRAX Screening in Men with Prostate Cancer.Journal of Clinical Densitometry.  19:430-435. 2016
2016 Pelvic Radiotherapy versus Radical Prostatectomy with Limited Lymph Node Sampling for High-Grade Prostate Adenocarcinoma.Prostate Cancer.  2016:2674954. 2016
2015 Increased radiation dose heterogeneity within the prostate predisposes to urethral strictures in patients receiving moderately hypofractionated prostate radiation therapy.Practical Radiation Oncology.  5:338-342. 2015
2015 Patterns of Failure for Lymph Node-Positive Resected Pancreatic Adenocarcinoma After Adjuvant Radiotherapy or Gemcitabine-based Chemotherapy Alone.Journal of Gastrointestinal Cancer.  46:149-155. 2015
2014 Hypofractionated stereotactic radiosurgery with concurrent bevacizumab for recurrent malignant gliomas: the University of Alabama at Birmingham experience.Neuro Oncology Practice.  1:172-177. 2014
2014 Reduced radiation tolerance of penile structures associated with dose-escalated hypofractionated prostate radiotherapy.Urology.  84:1383-1387. 2014
2014 Reply: To PMID 25440987.Urology.  84:1388. 2014
2014 PSA response to neoadjuvant androgen deprivation is an independent prognostic marker and may identify patients who benefit from treatment escalation.Urologic Oncology: Seminars and Original Investigations.  32:687-693. 2014
2014 Different rectal toxicity tolerance with and without simultaneous conventionally-fractionated pelvic lymph node treatment in patients receiving hypofractionated prostate radiotherapy.Radiation Oncology.  9:129. 2014
2013 Efficacy and toxicity of conventionally fractionated pelvic radiation with a hypofractionated simultaneous versus conventionally fractionated sequential boost for patients with high-risk prostate cancer.Acta Oncologica.  52:1181-1188. 2013
2013 Patient benefit from salvage radiation for prostate cancer.Journal of Clinical Oncology.  31:175. 2013
2013 Spontaneous spinal epidural abscess presenting in a previously healthy young adult man.Case Reports in Medicine.  2013:872148. 2013
2012 Hypofractionated Prostate Radiotherapy with or without Conventionally Fractionated Nodal Irradiation: Clinical Toxicity Observations and Retrospective Daily Dosimetry.Prostate Cancer.  2012:546794. 2012
2011 Efficacy and rectal toxicity of hypofractionated radiation therapy with daily image guidance.Journal of Clinical Oncology.  29:85. 2011

Principal Investigator On

  • Private Grant  awarded by COLLEGIUM PHARMACEUTICAL 2018 - 2020
  • Private Grant  awarded by VARIAN MEDICAL SYSTEMS, INC. 2018
  • Education And Training

  • Bachelor of Science or Mathematics, University of Alabama at Birmingham
  • Doctor of Medicine, University of Alabama at Birmingham
  • Master of Sciences or Mathematics, University of Alabama at Birmingham
  • Birmingham Baptist Health Systems, Internship 2013
  • University of Alabama at Birmingham, Residency 2017
  • Full Name

  • Andrew McDonald